Acute respiratory distress syndrome: Difference between revisions
From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
No edit summary |
||
Line 1: | Line 1: | ||
== |
== Background == |
||
* Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes |
* Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes |
||
Line 6: | Line 6: | ||
** V<s>T</s> 6mL/kg predicted body weight, plateau pressure ≤30 cmH<s>2</s>O, SpO2 88-95%, and pH 7.3-7.45 |
** V<s>T</s> 6mL/kg predicted body weight, plateau pressure ≤30 cmH<s>2</s>O, SpO2 88-95%, and pH 7.3-7.45 |
||
== Definition == |
=== Definition === |
||
* Syndrome of diffuse alveolar and interstitial edema |
* Syndrome of diffuse alveolar and interstitial edema |
||
* "[https://doi.org/10.1007/s00134-005-2627-z Baby lung]": small effective lung volume, because the dependent portions are filled with fluid |
* "[https://doi.org/10.1007/s00134-005-2627-z Baby lung]": small effective lung volume, because the dependent portions are filled with fluid |
||
== |
===[https://doi.org/10.1001/jama.2012.5669 Berlin Definition (2012)]=== |
||
* Syndrome, not disease, per European task force in 2012 |
* Syndrome, not disease, per European task force in 2012 |
||
Line 18: | Line 18: | ||
* Chest imaging bilateral opacities not otherwise explained |
* Chest imaging bilateral opacities not otherwise explained |
||
* Severity based on oxygenation |
* Severity based on oxygenation |
||
** Mild: ratio of PaO< |
** Mild: ratio of PaO<sub>2</sub>/FiO<sub>2</sub> between 200-300 with PEEP over 5 cmH<sub>2</sub>O (27% mortality) |
||
** Moderate: ratio between 100 and 200 with PEEP over 5 cmH< |
** Moderate: ratio between 100 and 200 with PEEP over 5 cmH<sub>2</sub>O (32% mortality) |
||
** Severe: ratio below 100 with PEEP over 5 cmH< |
** Severe: ratio below 100 with PEEP over 5 cmH<sub>2</sub>O (45% mortality) |
||
== |
=== Etiologies === |
||
* Direct |
* Direct |
||
Line 39: | Line 39: | ||
** Amniotic fluid embolism |
** Amniotic fluid embolism |
||
== Pathophysiology == |
=== Pathophysiology === |
||
* Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis |
* Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis |
||
* Type I pneumocytes replaced with type II |
* Type I pneumocytes replaced with type II |
||
* Increased alveolar permeability leading to non-hydrostatic pulmonary edema |
|||
* Lungs become less compliant, due to a decrease in the available lung volume |
* Lungs become less compliant, due to a decrease in the available lung volume |
||
⚫ | |||
⚫ | |||
== Differential Diagnosis == |
== Differential Diagnosis == |
||
* ARDS (50%) |
* ARDS (50%) |
||
* Pneumonia (25%) |
* [[Pneumonia]] (25%) |
||
* Pulmonary edema (11%) |
* [[Pulmonary edema]] (11%) |
||
* Invasive aspergillosis (6%) |
* [[Invasive aspergillosis]] (6%) |
||
* Pulmonary embolism (3%) |
* [[Pulmonary embolism]] (3%) |
||
* Other (5%) |
* Other (5%) |
||
⚫ | |||
⚫ | |||
== Investigations == |
== Investigations == |
||
Line 67: | Line 68: | ||
== Management == |
== Management == |
||
=== All Patients === |
|||
* Lung-protective ventilation (see [[ARDS ventilation protocol]]) |
* Lung-protective ventilation (see [[ARDS ventilation protocol]]) |
||
** Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45 |
** Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45 |
||
** Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in |
** Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in 1 mL/kg increments until plateau pressures <30 or tidal volume 4mL/kg |
||
** PEEP over 15 cmH<s>2</s>O [https://doi.org/10.1001/jama.2010.218 may be protective in severe ARDS] |
** PEEP over 15 cmH<sub><s>2</s></sub>O [https://doi.org/10.1001/jama.2010.218 may be protective in severe ARDS] |
||
** Permissive hypercapnia to |
** Permissive hypercapnia to CO<sub>2</sub> 60-70 and pH 7.2-7.25, if needed |
||
⚫ | |||
* Maintain euvolemia |
* Maintain euvolemia |
||
=== Severe ARDS === |
|||
⚫ | |||
* vv-[[ECMO]] |
|||
[[Category:Critical care]] |
[[Category:Critical care]] |
Revision as of 02:28, 29 August 2021
Background
- Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes
- Severity based on P:F ratio: severe <100, moderate 100-200, and mild 200-300
- Lung protective ventilation reduces mortality
- V
T6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45
- V
Definition
- Syndrome of diffuse alveolar and interstitial edema
- "Baby lung": small effective lung volume, because the dependent portions are filled with fluid
Berlin Definition (2012)
- Syndrome, not disease, per European task force in 2012
- Timing: within 1 week of a known insult
- Origin of edema: not cardiac or hydrostatic edema
- Chest imaging bilateral opacities not otherwise explained
- Severity based on oxygenation
- Mild: ratio of PaO2/FiO2 between 200-300 with PEEP over 5 cmH2O (27% mortality)
- Moderate: ratio between 100 and 200 with PEEP over 5 cmH2O (32% mortality)
- Severe: ratio below 100 with PEEP over 5 cmH2O (45% mortality)
Etiologies
- Direct
- Pneumonia
- Aspiration
- Inhalational injury
- Pulmonary contusion
- Near-drowning
- Indirection
- Sepsis
- Major trauma
- Multiple blood product transfusions
- Pancreatitis
- Shock
- Drug overdose
- Amniotic fluid embolism
Pathophysiology
- Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis
- Type I pneumocytes replaced with type II
- Increased alveolar permeability leading to non-hydrostatic pulmonary edema
- Lungs become less compliant, due to a decrease in the available lung volume
Clinical Manifestations
- Dyspnea and escalating ventilatory requirements following a known cause of ARDS
Differential Diagnosis
- ARDS (50%)
- Pneumonia (25%)
- Pulmonary edema (11%)
- Invasive aspergillosis (6%)
- Pulmonary embolism (3%)
- Other (5%)
Investigations
- Chest x-ray showing bilateral infiltrates
- Bronchoalveolar lavage (BAL)
- Excludes the diagnosis if less than 5% neutrophils (can be over 80% in ARDS)
- Suggestive if lavage to plasma protein ratio > 0.7 (less than 0.5 in hydrostatic edema)
Management
All Patients
- Lung-protective ventilation (see ARDS ventilation protocol)
- Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45
- Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in 1 mL/kg increments until plateau pressures <30 or tidal volume 4mL/kg
- PEEP over 15 cmH
2O may be protective in severe ARDS - Permissive hypercapnia to CO2 60-70 and pH 7.2-7.25, if needed
- Maintain euvolemia
Severe ARDS
- Prone positioning
- vv-ECMO